A couple of studies have demonstrated an increased expression of phospho-ERK 1⁄2, mitogen-activated protein kinase (MAPK), phospho-Akt, and phospho-mTor in a small group of canine astrocytomas [10,23]. The gene discussed is MTOR; the disease is astrocytoma (excluding glioblastoma).